Page last updated: 2024-09-03

celastrol and Experimental Hepatoma

celastrol has been researched along with Experimental Hepatoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Han, LZ; Jin, X; Lee, JJ; Liang, H; Ma, J; Mi, C; Shi, H	1

Other Studies

1 other study(ies) available for celastrol and Experimental Hepatoma

Article	Year
Celastrol inhibits the HIF-1α pathway by inhibition of mTOR/p70S6K/eIF4E and ERK1/2 phosphorylation in human hepatoma cells. Oncology reports, 2014, Volume: 32, Issue:1 Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Liver Neoplasms; Liver Neoplasms, Experimental; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Neoplasm Invasiveness; Pentacyclic Triterpenes; Phosphorylation; Proteolysis; Triterpenes; Xenograft Model Antitumor Assays	2014

Article

Year

Celastrol inhibits the HIF-1α pathway by inhibition of mTOR/p70S6K/eIF4E and ERK1/2 phosphorylation in human hepatoma cells.

Oncology reports, 2014, Volume: 32, Issue:1

Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Liver Neoplasms; Liver Neoplasms, Experimental; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Neoplasm Invasiveness; Pentacyclic Triterpenes; Phosphorylation; Proteolysis; Triterpenes; Xenograft Model Antitumor Assays

2014